Skip to main content
Clinical Trials/NCT04030468
NCT04030468UnknownNot Applicable

Effectiveness of Informative and/or Educational Interventions Aimed at Improving the Appropriate Use of Drugs Designed for General Practitioners and Their Patients

University of Milan1 site in 1 country4,840 target enrollmentStarted: April 20, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
4,840
Locations
1
Primary Endpoint
Inappropriate drug prescription and use indicators

Study Overview

Brief Summary

Pharmacological intervention is an essential step in health promotion. However, lots of drugs are often used in inappropriate ways, especially in elderly patients. This study is aiming at evaluating the effectiveness of educational and/or informative interventions addressed to general practitioners and their adult patients in Italy, in order to improve appropriateness of prescribing in primary care.

Detailed Description

EDU.RE.DRUG project is a prospective, multicentre, open-label, parallel-arm, controlled, pragmatic trial directed to general practitioners (GPs) and their patients from two Italian regions (Campania and Lombardy), with the objective of investigating the practice of prescribing among GPs to highlight the most frequent events of inappropriateness and to implement ad hoc interventions for GPs and patients.

Appropriateness of prescribing in general practice will be assessed by evaluating selected prescribing, consumption and adherence indicators, using Regional administrative pharmaceutical prescription databases.

Primary care physicians and their patients will be assigned to four trial arms: informative intervention (leaflets and posters for patients), educational intervention (feedback reports and online CME courses for GPs), combined interventions, or no intervention. Intervention effectiveness will be assessed measuring the variation in rates of inappropriate prescription indicators after 1-year of follow-up.

EDU.RE.DRUG project will provide with improvements in the prescribing performance of GPs and in patients' adherence to treatment, with relevant clinical implications in terms of rational and safe use of drugs and optimized patient care, and with economic benefits (optimization of available resources use and savings in direct and indirect health costs).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •general practitioners of the Italian National Health System (NHS) operating at December 31, 2016 belonging to the 8 Local Health Units involved in the project

Exclusion Criteria

  • •primary care pediatricians

Arms & Interventions

Control

No Intervention

No intervention

General practitioners and patients

Experimental

Combined strategy

Intervention: Educational intervention addressed to general practitioners (Other)

General practitioners and patients

Experimental

Combined strategy

Intervention: Informative intervention addressed to patients (Other)

General practitioners

Experimental

Educational intervention

Intervention: Educational intervention addressed to general practitioners (Other)

Patients

Experimental

Informative intervention

Intervention: Informative intervention addressed to patients (Other)

Outcomes

Primary Outcomes

Inappropriate drug prescription and use indicators

Time Frame: 30 months

Changes in prevalences of selected potentially inappropriate prescribing (including drug-drug interactions, duplicate therapies, inappropriate drugs in older people and drugs with high anticholinergic and sedative burden), consumption and adherence indicators between baseline and after the intervention

Secondary Outcomes

  • GP's satisfaction(30-36 months)
  • Health Technology Assessment of intervention implemented(30-36 months)
  • Predictive factors of inappropriate prescribing(30-36 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elena Tragni

Researcher at Epidemiology and Preventive Pharmacology Centre

University of Milan

Study Sites (1)

Loading locations...

Similar Trials